☰ Navigation Tabs
Pharmacological characterisation and NMR structure of the novel mu-conotoxin SxIIIC, a potent irreversible NaV channel inhibitor
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H TOCSY 1 mg/mL SxIIIC 90% H2O/10% D2O 4 ambient 298 Bruker AVANCE III 600 2 2D 1H-1H NOESY 1 mg/mL SxIIIC 90% H2O/10% D2O 4 ambient 298 Bruker AVANCE III 600 3 2D 1H-15N HSQC 1 mg/mL SxIIIC 90% H2O/10% D2O 4 ambient 298 Bruker AVANCE III 600 4 2D 1H-1H TOCSY 1 mg/mL SxIIIC 100% D2O 4 ambient 298 Bruker AVANCE III 600 5 2D 1H-1H NOESY 1 mg/mL SxIIIC 100% D2O 4 ambient 298 Bruker AVANCE III 600 6 2D 1H-13C HSQC 1 mg/mL SxIIIC 100% D2O 4 ambient 298 Bruker AVANCE III 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 600
NMR Refinement Method Details Software torsion angle dynamics CNS
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 100 Conformers Submitted Total Number 20 Representative Model 1 (1)
Computation: NMR Software # Classification Version Software Name Author 1 collection TopSpin Bruker Biospin 2 processing TopSpin Bruker Biospin 3 data analysis TopSpin Bruker Biospin 4 peak picking CcpNmr Analysis CCPN 5 chemical shift assignment CcpNmr Analysis CCPN 6 structure calculation CYANA Guntert, Mumenthaler and Wuthrich 7 refinement CNS Brunger, Adams, Clore, Gros, Nilges and Read